This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It
focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose
levels, and identifying and managing long-term complications....
Objetivo general: Entregar recomendaciones basadas en evidencia para prevenir y tratar las lesiones de caries radiculares en adultos de 60 años y más....
Esta guía aborda aspectos relacionados con el diagnóstico y el tratamiento de la acalasia en adultos...
Esta guía aborda aspectos relacionados con el diagnóstico y el tratamiento médico y quirúrjico del vólvulo de colon en el adulto...
Hacer recomendaciones basadas en la mejor evidencia disponible para el diagnóstico clínico y paraclínico de las Distrofias Musculares.
Hacer recomendaciones basadas en la mejor evidencia disponible para el tratamiento y rehabilitación de las personas con Distrofia Muscular.
Hacer recomendaciones basa...
Muscular Dystrophy, Duchenne/therapy,
Muscular Dystrophy, Duchenne/diagnosis,
Muscular Dystrophy, Duchenne/rehabilitation,
Myotonic Dystrophy/diagnosis,
Myotonic Dystrophy/therapy,
Myotonic Dystrophy/rehabilitation,
Early Diagnosis,
Comprehensive Health Care
The objective of this guideline is to provide recommendations on the intake of free sugars to reduce the risk of NCDs in adults and children, with a particular focus on the prevention and control of unhealthy weight gain and dental caries. The recommendations in this guideline can be used by policy-make...
El objetivo principal de esta Guía es recoger recomendaciones para el diagnóstico y el tratamiento de mujeres con cáncer de mama metastásico....
Breast Neoplasms/diagnosis,
Breast Neoplasms/therapy,
Neoplasm Metastasis,
Trastuzumab/therapeutic use,
Tamoxifen/therapeutic use,
Goserelin/therapeutic use,
Aromatase Inhibitors/therapeutic use,
Everolimus/therapeutic use,
Positron-Emission Tomography/methods,
Positron Emission Tomography Computed Tomography/methods,
Bone Neoplasms/secondary,
Biopsy,
GRADE Approach,
Antineoplastic Agents/administration & dosage
In 2015 WHO updated the mhGAP guidelines, first issued in 2009, for the management of mental, neurological and substance use (MNS) disorders. In order to reduce the gap and to enhance the capacity of Member States to respond to the growing challenge, the World Health Organization (WHO) developed the Ment...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, presents current WHO guidance on the safety of various contraceptive methods for use in the context of spe...